9.2 Gluconeogenesis Bypass Enzymes & the Pentose Phosphate Pathway

9.2 Gluconeogenesis Bypass Enzymes & the Pentose Phosphate Pathway

Gluconeogenesis: The Four Thermodynamic Bypass Enzymes

Gluconeogenesis synthesizes glucose from non-carbohydrate precursors during periods of prolonged fasting (>12–16 hours), starvation, or intense exertion. It occurs primarily in the liver (~90%) and to a lesser extent in the renal cortex (~10%).

Gluconeogenesis is not a simple reversal of glycolysis. The three glycolytic reactions characterized by large negative $\Delta G$ values (Steps 1, 3, and 10) are thermodynamically irreversible in vivo. Gluconeogenesis overcomes these energetic barriers through four specialized bypass enzymes:

Bypass 1: Overcoming Pyruvate Kinase (Pyruvate $\to$ PEP)

Converting pyruvate back to phosphoenolpyruvate requires two coordinated enzymatic steps and the consumption of two high-energy phosphate bonds per pyruvate:

1. Pyruvate Carboxylase (Mitochondrial Matrix): $$\text{Pyruvate} + \text{CO}_2 + \text{ATP} + \text{H}_2\text{O} \xrightleftharpoons{\text{Biotin}} \text{Oxaloacetate (OAA)} + \text{ADP} + \text{P}_i$$ Pyruvate enters the mitochondrial matrix via the mitochondrial pyruvate carrier (MPC). Pyruvate carboxylase carboxylation requires the covalently attached vitamin cofactor biotin (Vitamin $\text{B}_7$), which carries activated $\text{CO}_2$. Acetyl-CoA is an absolute, obligate allosteric activator; without high levels of acetyl-CoA (signaling active fatty acid $\beta$-oxidation), pyruvate carboxylase is inactive.
2. The Malate-Aspartate Intermediate Transport: The inner mitochondrial membrane lacks a transport protein for oxaloacetate. OAA is therefore reduced to malate by mitochondrial malate dehydrogenase (consuming matrix NADH), exported into the cytosol via the dicarboxylate carrier, and re-oxidized back to OAA by cytosolic malate dehydrogenase (generating cytosolic NADH required for downstream GAPDH reversal).
3. Phosphoenolpyruvate Carboxykinase (PEPCK, Cytosol): $$\text{Oxaloacetate} + \text{GTP} \longrightarrow \text{Phosphoenolpyruvate (PEP)} + \text{GDP} + \text{CO}_2$$ PEPCK decarboxylates OAA and drives phosphorylation of the enol using GTP, releasing the same $\text{CO}_2$ molecule incorporated by pyruvate carboxylase.

Bypass 2: Overcoming PFK-1 (Fructose-1,6-Bisphosphate $\to$ Fructose-6-Phosphate)

• Fructose-1,6-Bisphosphatase-1 (FBPase-1) catalyzes the simple hydrolytic removal of the C1 phosphate: $$\text{Fructose-1,6-bisphosphate} + \text{H}_2\text{O} \longrightarrow \text{Fructose-6-phosphate} + \text{P}_i$$ This reaction bypasses PFK-1 without regenerating ATP. FBPase-1 is the rate-limiting regulatory enzyme of gluconeogenesis. It is strongly inhibited by F-2,6-BP and AMP, and stimulated by ATP and citrate.

Bypass 3: Overcoming Hexokinase (Glucose-6-Phosphate $\to$ Glucose)

• Glucose-6-Phosphatase (G6Pase) hydrolyzes G6P to produce free glucose: $$\text{Glucose-6-phosphate} + \text{H}_2\text{O} \longrightarrow \text{D-Glucose} + \text{P}_i$$ G6Pase is embedded within the endoplasmic reticulum membrane, with its catalytic site facing the ER lumen. Free glucose is transported into the cytosol and exported to the blood via GLUT2 uniporters.
  • Tissue Localization Note: G6Pase is expressed in the liver and renal cortex, but is completely absent in skeletal muscle. Consequently, skeletal muscle cannot release free glucose into the systemic circulation; muscle glycogen is strictly reserved for autonomous contraction.

Non-Carbohydrate Gluconeogenic Precursors

• Glycerol: Released by adipose tissue during triacylglycerol lipolysis. Phosphorylated by hepatic glycerol kinase to glycerol-3-phosphate, then oxidized by glycerol-3-phosphate dehydrogenase to DHAP, entering the gluconeogenic backbone.
• Lactate: Derived from anaerobic glycolysis in muscle and RBCs, converted to pyruvate via LDH.
• Glucogenic Amino Acids: Derived from muscle proteolysis during prolonged fasting. Alanine is transaminated to pyruvate by alanine aminotransferase (ALT); glutamine and glutamate enter via $\alpha$-ketoglutarate. Leucine and lysine are strictly ketogenic and cannot yield net glucose.

---

The Pentose Phosphate Pathway (Hexose Monophosphate Shunt)

The Pentose Phosphate Pathway (PPP) is an alternative cytosolic pathway branching from glucose-6-phosphate. It consumes no ATP and produces no direct high-energy phosphate bonds, fulfilling two non-energetic cellular imperatives:

1. Generating NADPH for reductive biosynthesis and cellular antioxidant defense.
2. Generating ribose-5-phosphate for de novo nucleotide and nucleic acid synthesis.

The Oxidative Phase (Irreversible)

The oxidative phase generates 2 NADPH and 1 $\text{CO}_2$ per glucose-6-phosphate molecule:

1. Glucose-6-Phosphate Dehydrogenase (G6PD): Catalyzes the rate-limiting oxidation of G6P to 6-phosphoglucono-$\delta$-lactone, reducing $\text{NADP}^+$ to NADPH.
2. 6-Phosphogluconolactonase: Hydrolyzes the lactone to 6-phosphogluconate.
3. 6-Phosphogluconate Dehydrogenase: Oxidatively decarboxylates 6-phosphogluconate to ribulose-5-phosphate, releasing $\text{CO}_2$ and reducing a second $\text{NADP}^+$ to NADPH.

Regulation: G6PD is allosterically regulated by the [$\text{NADP}^+$]/[NADPH] ratio. It is powerfully inhibited by high levels of its product, NADPH, and stimulated when cellular consumption of NADPH elevates [$\text{NADP}^+$].

The Non-Oxidative Phase (Reversible)

The non-oxidative phase interconverts phosphorylated pentoses and glycolytic intermediates according to cellular demands:

• Ribulose-5-Phosphate Isomerase: Converts ribulose-5-phosphate to ribose-5-phosphate (for DNA and RNA synthesis).
• Ribulose-5-Phosphate 3-Epimerase: Converts ribulose-5-phosphate to xylulose-5-phosphate.
• Transketolase & Transaldolase: Catalyze reversible carbon-shuffling reactions ($C_5 + C_5 \rightleftharpoons C_3 + C_7 \rightleftharpoons C_6 + C_4$). Transketolase transfers two-carbon units and strictly requires Thiamine Pyrophosphate (TPP, Vitamin $\text{B}_1$) as a prosthetic cofactor. In clinical practice, erythrocyte transketolase activity assays evaluate thiamine nutritional status (such as in Wernicke-Korsakoff syndrome).

Biological Roles of NADPH vs. NADH

Whereas $\text{NAD}^+$ and NADH are maintained at a high oxidized-to-reduced ratio ([$\text{NAD}^+$]/[NADH] $> 700$) to promote catabolic oxidation, $\text{NADP}^+$ and NADPH are maintained at a low ratio ([NADPH]/[$\text{NADP}^+$] $> 100$) to drive anabolic reduction:

• Fatty Acid and Cholesterol Synthesis: Provides hydride donors for lipid biogenesis in liver and adipose tissue.
• Glutathione Reduction: Erythrocytes are exposed to high endogenous oxygen tension and reactive oxygen species (ROS). Glutathione peroxidase neutralizes hydrogen peroxide ($2\text{ GSH} + \text{H}_2\text{O}_2 \to \text{GSSG} + 2\text{ H}_2\text{O}$). To regenerate reduced glutathione (GSH), glutathione reductase requires NADPH. In patients with G6PD deficiency (X-linked recessive), erythrocytes fail to generate adequate NADPH, causing glutathione depletion, oxidative hemoglobin precipitation (Heinz bodies), and acute episodic hemolytic anemia upon exposure to oxidative stressors (e.g., fava beans, infection, or antimalarial drugs like primaquine).
• Respiratory Burst: NADPH oxidase in neutrophils and macrophages reduces molecular oxygen to superoxide ($\text{O}_2^{\bullet-}$), initiating phagocytic pathogen killing.

---

Comparison of Key Metabolic Checkpoints